Qu Jiafei, Yu Feiyan, Hong Yingying, Guo Yanyan, Sun Lisha, Li Xuefen, Zhang Jianyun, Zhang Heyu, Shi Ruirui, Chen Feng, Li Tiejun
Department of Oral Pathology, Peking University School and Hospital of Stomatology, Beijing, China.
Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, China.
Oral Oncol. 2015 Jan;51(1):40-5. doi: 10.1016/j.oraloncology.2014.09.016. Epub 2014 Nov 18.
Keratocystic odontogenic tumors (KCOTs) are benign cystic lesions of the jaws that occur sporadically in isolation or in association with nevoid basal cell carcinoma syndrome (NBCCS). The protein patched homolog 1 gene (PTCH1) is associated with NBCCS development and tumor genesis associated with this syndrome. However, previous studies have revealed that more than 85% of syndromic KCOTs and less than 30% of sporadic KCOTs harbor PTCH1 mutations. The significantly lower PTCH1 mutation rates observed in sporadic KCOTs suggest that they serve a minor role in pathogenesis. We aimed to discern the importance of PTCH1 mutations in sporadic KCOTs.
PTCH1 mutational analysis was performed with 19 new sporadic KCOT cases by direct sequencing of epithelial lining samples separated from fibrous capsules. Using this approach, we further reexamined 9 sporadic KCOTs that were previously reported to lack PTCH1 mutations by our group.
Nineteen PTCH1 mutations were detected in patient samples from 16/19 new cases (84%) all these mutations were absent in fibrous tissues and peripheral blood specimens from the same patients. We also identified four PTCH1 mutations in 3/9 patients (33%) that were previously undetected.
These data indicated that PTCH1 mutations occur in sporadic KCOTs at a higher rate than previously suspected, owing to the masking effects of the attached stromal tissues in the test samples. These results suggest that the PTCH1 gene plays a significant role in the pathogenesis of sporadic KCOTs, which is comparable to that observed in NBCCS patients.
牙源性角化囊性瘤(KCOTs)是颌骨的良性囊性病变,可散发孤立出现或与痣样基底细胞癌综合征(NBCCS)相关。蛋白patched同源物1基因(PTCH1)与NBCCS的发生以及与该综合征相关的肿瘤发生有关。然而,先前的研究表明,超过85%的综合征性KCOTs和不到30%的散发性KCOTs存在PTCH1突变。在散发性KCOTs中观察到的PTCH1突变率显著较低,表明它们在发病机制中起次要作用。我们旨在探讨PTCH1突变在散发性KCOTs中的重要性。
对19例新的散发性KCOT病例进行PTCH1突变分析,通过对从纤维包膜分离的上皮衬里样本进行直接测序。使用这种方法,我们进一步重新检查了9例先前被我们小组报告为缺乏PTCH1突变的散发性KCOTs。
在19例新病例中的16例(84%)患者样本中检测到19个PTCH1突变,所有这些突变在同一患者的纤维组织和外周血标本中均未出现。我们还在9例患者中的3例(33%)中鉴定出4个先前未检测到的PTCH1突变。
这些数据表明,由于测试样本中附着的基质组织的掩盖作用,PTCH1突变在散发性KCOTs中的发生率高于先前的怀疑。这些结果表明,PTCH1基因在散发性KCOTs的发病机制中起重要作用,这与在NBCCS患者中观察到的情况相当。